Comparison Chart BLS Pharmaceuticals Limited

Stocks

BLS

AU0000477796

Biotechnology & Medical Research

Market Closed - Australian S.E. Other stock markets 02:10:17 2026-07-24 EDT			5-day change	1st Jan Change
0.8400 ^AUD	-0.59%		-2.89%	+100.00%

06-02	Bioxyne Limited Announces Appointment of Edward Myer as Independent Non-Executive Director and Independent Chair of Audit and Finance Committee	CI
05-11	Bioxyne secures a$50m exclusive German supply agreement with Adrex	RE

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	BLS PHARMACEUTICALS LIMITED	Other Biotechnology & Medical Research	-0.59%	-2.89%	+100.00%	+68.00%	+200.00%	135M